Suppr超能文献

乌干达和喀麦隆女性乳腺癌易感基因遗传突变的流行情况。

Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.

机构信息

Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.

Hôpital Général Yaoundé, Yaoundé, Cameroon.

出版信息

Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):359-367. doi: 10.1158/1055-9965.EPI-19-0506. Epub 2019 Dec 23.

Abstract

BACKGROUND

Sub-Saharan Africa (SSA) has a high proportion of premenopausal hormone receptor negative breast cancer. Previous studies reported a strikingly high prevalence of germline mutations in and among Nigerian patients with breast cancer. It is unknown if this exists in other SSA countries.

METHODS

Breast cancer cases, unselected for age at diagnosis and family history, were recruited from tertiary hospitals in Kampala, Uganda and Yaoundé, Cameroon. Controls were women without breast cancer recruited from the same hospitals and age-matched to cases. A multigene sequencing panel was used to test for germline mutations.

RESULTS

There were 196 cases and 185 controls with a mean age of 46.2 and 46.6 years for cases and controls, respectively. Among cases, 15.8% carried a pathogenic or likely pathogenic mutation in a breast cancer susceptibility gene: 5.6% in , 5.6% in , 1.5% in , 1% in , 0.5% in , 0.5% in , and 0.5% in . Among controls, 1.6% carried a mutation in one of these genes. Cases were 11-fold more likely to carry a mutation compared with controls (OR = 11.34; 95% confidence interval, 3.44-59.06; < 0.001). The mean age of cases with mutations was 38.3 years compared with 46.7 years among other cases without such mutations ( = 0.03).

CONCLUSIONS

Our findings replicate the earlier report of a high proportion of mutations in among patients with symptomatic breast cancer in SSA.

IMPACT

Given the high burden of inherited breast cancer in SSA countries, genetic risk assessment could be integrated into national cancer control plans.

摘要

背景

撒哈拉以南非洲(SSA)有很大比例的绝经前激素受体阴性乳腺癌。先前的研究报告称,尼日利亚乳腺癌患者中 和 种系突变的发生率极高。目前尚不清楚这种情况是否存在于其他 SSA 国家。

方法

从乌干达坎帕拉和喀麦隆雅温得的三级医院招募未按诊断时年龄和家族史选择的乳腺癌病例和未患乳腺癌的对照。对照组从同一医院招募,与病例年龄匹配。使用多基因测序面板检测种系突变。

结果

共纳入 196 例病例和 185 例对照,病例和对照的平均年龄分别为 46.2 岁和 46.6 岁。在病例中,15.8%携带乳腺癌易感性基因中的致病性或可能致病性突变:5.6%在 ,5.6%在 ,1.5%在 ,1%在 ,0.5%在 ,0.5%在 ,0.5%在 。对照中,有 1.6%携带这些基因中的一个突变。病例携带突变的可能性是对照的 11 倍(OR = 11.34;95%置信区间,3.44-59.06; < 0.001)。携带 突变的病例的平均年龄为 38.3 岁,而其他无此类突变的病例的平均年龄为 46.7 岁( = 0.03)。

结论

我们的研究结果复制了早期关于 SSA 有症状乳腺癌患者中 突变比例高的报告。

影响

鉴于 SSA 国家遗传性乳腺癌的负担沉重,遗传风险评估可以纳入国家癌症控制计划。

相似文献

1
Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):359-367. doi: 10.1158/1055-9965.EPI-19-0506. Epub 2019 Dec 23.
3
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
Clin Cancer Res. 2017 Oct 15;23(20):6113-6119. doi: 10.1158/1078-0432.CCR-16-3227. Epub 2017 Jul 19.
4
Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
Breast Cancer Res Treat. 2020 Jun;181(2):465-473. doi: 10.1007/s10549-020-05643-0. Epub 2020 Apr 21.
5
Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
Breast Cancer Res Treat. 2017 Oct;165(3):687-697. doi: 10.1007/s10549-017-4356-8. Epub 2017 Jun 29.
6
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Breast Cancer Res Treat. 2020 Feb;179(3):605-614. doi: 10.1007/s10549-019-05483-7. Epub 2019 Nov 25.
8
Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
PLoS One. 2016 Nov 30;11(11):e0165436. doi: 10.1371/journal.pone.0165436. eCollection 2016.

引用本文的文献

1
Germline Mutation in High-Risk Chinese Breast and Ovarian Cancer Patients.
Cancers (Basel). 2025 Jul 30;17(15):2524. doi: 10.3390/cancers17152524.
2
Current landscape of cancer genomics research in sub-Saharan Africa - a review of literature.
Front Oncol. 2025 Apr 17;15:1512005. doi: 10.3389/fonc.2025.1512005. eCollection 2025.
3
Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.
JAMA Netw Open. 2025 Apr 1;8(4):e255804. doi: 10.1001/jamanetworkopen.2025.5804.
4
The Current State of Breast Cancer Genetics in Populations of African Ancestry.
Genes (Basel). 2025 Feb 6;16(2):199. doi: 10.3390/genes16020199.
5
Application of genetic testing criteria for hereditary breast cancer in South Africa.
Breast Cancer Res Treat. 2025 Apr;210(2):477-486. doi: 10.1007/s10549-024-07585-3. Epub 2025 Jan 7.
6
"A Call To Action": The need for genetic counseling in Uganda.
Genet Med Open. 2024 Jul 30;2(Suppl 2):101879. doi: 10.1016/j.gimo.2024.101879. eCollection 2024.
7
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.
Eur J Hum Genet. 2024 Dec;32(12):1632-1639. doi: 10.1038/s41431-024-01705-9. Epub 2024 Oct 14.
8
Reclassification of Variants Following Renal Genetics Testing: Uncommon Yet Impactful for Diagnosis and Management.
Kidney Int Rep. 2024 Feb 6;9(5):1441-1450. doi: 10.1016/j.ekir.2024.01.055. eCollection 2024 May.
9
Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity.
Healthcare (Basel). 2024 Feb 12;12(4):462. doi: 10.3390/healthcare12040462.
10
Genetic contribution of breast cancer genes in women of black African origin.
Front Genet. 2023 Dec 13;14:1302645. doi: 10.3389/fgene.2023.1302645. eCollection 2023.

本文引用的文献

2
Inherited Breast Cancer in Nigerian Women.
J Clin Oncol. 2018 Oct 1;36(28):2820-2825. doi: 10.1200/JCO.2018.78.3977. Epub 2018 Aug 21.
3
Development of a Breast Cancer Risk Prediction Model for Women in Nigeria.
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):636-643. doi: 10.1158/1055-9965.EPI-17-1128. Epub 2018 Apr 20.
5
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12.
7
Mutations in context: implications of BRCA testing in diverse populations.
Fam Cancer. 2018 Oct;17(4):471-483. doi: 10.1007/s10689-017-0038-2.
8
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
9
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验